Consider CIRM as a bank. We don’t conduct research ourselves: we fund it – and have become the largest dedicated funder of stem cell and gene therapy

Researchers demonstrate anticounterfeiting method that uses DNA oligos integrated into pharmaceutical products.

Controversial and divisive, but Kennedy’s expertise is intended for one thing: change.

From AI, to hot-melt extrusion, continuous processing, generics, and more – check out our free eBook.

Claus Zieler reflects on his time at Astellas and his role at EFPIA.

Claus Zieler from Astellas and EFPIA addresses the challenges facing innovation in Europe, including regulatory burdens and access to medicines.

We get more details on the ready-to-use technologies alliance forged between Schott Pharma, Gerresheimer, and Stevanato.

Looking for words of wisdom and tips on being a leader and advancing your career in pharma?

How whole genome sequencing is being used to understand the bacterium that causes syphilis – and what it means for vaccine development.

Here’s a look at recent violations cited in FDA Warning Letters: fly pupae, cross contamination, trial dosing errors, and more.